Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-01

FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Bimatoprost from Apotex Corp. under an Abbreviated New Drug Application (ANDA). The approval confirms the generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)